Press
December 2020
Moderna Stock Is More Than The Covid-19 Vaccine
“Moderna’s role in fighting the pandemic provided some significant benefits,” said Asher Rogovy, who is the Chief Investment Officer at Magnifina, LLC. “Operation Warp Speed provided Moderna with $1.53 billion to help its R&D and production capacity. The new supply chain will be reusable after the pandemic and Moderna should be able to produce new therapies at scale much quicker.”
What is a small-cap stock?
“Small-cap stocks can have significant growth potential and often remain undervalued by the market,” says Asher Rogovy, chief investment officer at Magnifina, a portfolio management firm.
Bond Index Funds
A list of the best bond index funds would be incomplete without a nod to the tax-exempt offerings. Recommended by Asher Rogovy, chief investment officer at Magnifina, VTEAX is a stalwart in this sector. (N.B. this suggestion does not constitute investment advice)
November 2020
What is market cap?
“Everyone is working to measure a company’s true market value,” Asher Rogovy, Chief Investment Officer at Magnifina, says. “Whoever understands the true value can profit by trading mispriced stocks. Market capitalization represents how investors, on average, estimate true market value. It’s one indicator of market value and a great starting point for analysis.”
Best financial tips for baby boomers, Gen X, millennials & Gen Z
If you’re still not investing your money, Asher Rogovy of Magnifina says that it’s never too soon or too late to get your start. “Young investors may feel apprehensive because they are waiting for a good deal when markets fall,” says Rogovy. “The truth is, it’s impossible to time the market perfectly.” Instead, an excellent strategy to avoid missing out is to invest a set amount every month whether markets are up or down. He also suggests you stay disciplined. “Young investors have the benefit of time, and the stock market usually makes new highs within years of a previous top.”
How to invest in penny stocks
To avoid scams, Asher Rogovy, chief investment officer at Magnifina LLC, emphasizes the importance of thoroughly researching the companies you’re interested in.
Rogovy, too, stresses caution. “It’s certainly appealing to think your stock may increase to 10 times its value, but this is exceedingly rare. If an investment seems too good to be true, it probably is.”
Upheaval in society has people turning to socially responsible investing
“In terms of performance, we caution our clients that restricting the list of potential investments may result in lower portfolio returns,” says Asher Rogovy, chief investment officer at Magnifina in Manhattan.
Advice From Mark Cuban, Warren Buffett and Other Experts That Can Help You Survive a Crisis
“Over the long term, the stock market news will be good. In the 20th century, the United States endured two world wars and other traumatic and expensive military conflicts; the Depression; a dozen or so recessions and financial panics; oil shocks; a flu epidemic; and the resignation of a disgraced president. Yet the Dow rose from 66 to 11,497.”
Warren Buffett wrote these prescient words in The New York Times op-ed in 2008 during the Great Recession. Now, in the bellows of the COVID-19 recession, these words ring true again to Asher Rogovy, chief investment officer at Magnifina.
“The pandemic is certainly the biggest economic event which has occurred for many years [and] there was a violent market reaction in March and April, but many analysts predict that by this time next year, it will no longer be affecting the stock market,” Rogovy said. “This is Buffett’s wisdom: to invest with a very very long-term horizon. He is the master at putting aside emotions and focusing strictly on the numbers. According to our research, only 30% of bear markets since 1950 have lasted more than three and a half years. The most recent one didn’t even last three quarters.”
October 2020
Is It Too Late for Novavax to Profit From a Covid-19 Vaccine?
“Novavax uses a tried-and-true method to produce immunity,” said Asher Rogovy, who is the Chief Investment Officer at Magnifina. “The news media and social media are almost certain to hype up reports of side effects during the first round of vaccination. Vaccine hesitancy is growing, and in 2018 almost half of US citizens refused a flu vaccine. Waiting a few more months for Novavax’s vaccine candidate would appeal to vaccine hesitant individuals who are not fully anti-vax.”